Directorate of Clinical Affairs, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar.
BMC Public Health. 2020 May 3;20(1):611. doi: 10.1186/s12889-020-08609-5.
In Qatar, prevalence of metabolic components is significantly higher compared to other countries. It is therefore urgent to understand the prevalence of metabolic syndrome (MetS) with the goal of identifying etiologic factors in Qatar. This study was undertaken to estimate the prevalence of MetS, by age, gender and nationality within primary care settings in Qatar. In addition, it determined the independent effects of risk factors on the prevalence of MetS.
A cross-sectional study design was used. Data for individuals aged ≥18 and who visited a publicly funded primary health centre in Qatar during 2017 were extracted from electronic medical records and analysed.
The findings showed that the prevalence of individual MetS components ranged between 48.5-60.3%. Overall prevalence of MetS was 48.8% (N = 62,492) in the study population. Prevalence of MetS increased with age. 50.3% of the population within the 40-49 year age group had MetS. In this age band, individuals were 5.1 times more likely of having MetS compared to the 18-29 year age group. MetS was slightly more prevalent in men (56 .7%) compared to women (42.5%). However, men were 1.33 times more likely of having MetS compared to women. The prevalence of MetS ranged between 20.6 - 60% across nationalities. It was most prevalent in Southern Asians (60%), followed by Northern Africans (50.7%) and Western Asians (excluding Qatar) (46.8%). Prevalence of MetS in Qataris was 43%. Southern Asians, Northern African and Western Asians were 1.73, 1.38 and 1.17 more likely to have MetS compared to Qataris.
The study provides essential epidemiological information required by decision makers. Although not nationally representative, this study is suggestive of a higher prevalence of MetS among a younger population, men and in Southern Asian, Northern African and Western Asian nationalities. Prevention, treatment and control of MetS is a public health problem in Qatar. More studies are needed to establish which public health interventions are likely to be effective in Qatar.
与其他国家相比,卡塔尔的代谢成分患病率显著更高。因此,迫切需要了解代谢综合征(MetS)的患病率,以确定卡塔尔的病因因素。本研究旨在估计在卡塔尔初级保健环境中按年龄、性别和国籍划分的 MetS 患病率。此外,还确定了危险因素对 MetS 患病率的独立影响。
采用横断面研究设计。从 2017 年在卡塔尔接受公共资助的初级保健中心就诊的年龄≥18 岁的个体的电子病历中提取数据并进行分析。
研究结果显示,单个 MetS 成分的患病率在 48.5%-60.3%之间。在研究人群中,MetS 的总体患病率为 48.8%(N=62492)。MetS 的患病率随年龄增长而增加。40-49 岁年龄组中 50.3%的人群患有 MetS。在该年龄组中,与 18-29 岁年龄组相比,个体患 MetS 的可能性高 5.1 倍。男性(56.7%)的 MetS 患病率略高于女性(42.5%)。然而,男性患 MetS 的可能性是女性的 1.33 倍。不同国籍的 MetS 患病率在 20.6%-60%之间。南亚人(60%)患病率最高,其次是北非(50.7%)和西亚(不包括卡塔尔)(46.8%)。卡塔尔人的 MetS 患病率为 43%。与卡塔尔人相比,南亚人、北非人和西亚人患 MetS 的可能性分别增加 1.73、1.38 和 1.17 倍。
本研究提供了决策者所需的基本流行病学信息。尽管本研究不具有全国代表性,但它表明,年轻人群、男性以及南亚人、北非人和西亚人群中 MetS 的患病率较高。MetS 的预防、治疗和控制是卡塔尔的一个公共卫生问题。需要开展更多研究以确定哪些公共卫生干预措施可能在卡塔尔有效。